Coronavirus
To visit the Select Subcommittee on the Coronavirus Crisis, click here.
In light of the ongoing Coronavirus crisis, the Committee on Oversight and Reform has been conducting oversight of our nation's preparedness for, and response to, the outbreak. The Committee's top priority is promoting the health and safety of the American people, and the information below is from the Committee's investigative activities, the Centers for Disease Control and Prevention (CDC), and other sources.
Oversight Committee Hearing Mentioned on NBC's Meet the Press, March 15, 2020:
Full Committee Activities:
More on Coronavirus
Washington, D.C. (Apr. 2, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after the Committee released new documents obtained from the Federal Emergency Management Agency (FEMA) showing that the agency has provided only a fraction of the personal protective equipment and critical medical supplies requested by five states and the District of Columbia:
Washington, D.C. (Apr. 2, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, sent a letter to the Pharmaceutical Research and Manufacturers of America (PhRMA) urging its member drug companies to commit to setting affordable prices for any medications that are or may be used to prevent or treat coronavirus, including vaccines.
Washington, D.C. – Fourteen House Committee Chairs sent a letter to Office of Management and Budget (OMB) Acting Director Russell Vought today requesting an immediate extension of public comment periods, hearings and meetings due to the ongoing coronavirus pandemic.
Washington, D.C. (Apr. 1, 2020)—Today, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, sent a letter urging the Food and Drug Administration (FDA) to use its authority to clear the market of e-cigarettes for the duration of the coronavirus pandemic and use all available tools to encourage Americans to stop smoking and vaping.
Washington, D.C. (Apr. 1, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Committee Member Rep. Alexandria Ocasio-Cortez, sent a letter urging the Food and Drug Administration (FDA) to revise its policy of turning away blood donations from gay and bisexual men in light of the long-term impacts of the coronavirus crisis on the nation's blood supply.
Washington, D.C. (Apr. 1, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Rep.
Washington, D.C. (Mar. 30, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after the Council of the Inspectors General on Integrity and Efficiency (CIGIE) announced the appointment of Acting U.S. Department of Defense Inspector General Glenn Fine to serve as the Chair of CIGIE's Pandemic Response Accountability Committee (PRAC):
Washington, D.C. (Mar. 30, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Rep.
On Monday, March 30, 2020, at 11:00 a.m.the Committee will hold a briefingfor Members with Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response at the Department of Health and Human Services (HHS); Brian Shuy, Chief of Staff to Dr.
On Monday, March 30, 2020, at 11:00 a.m.the Committee will hold a briefingfor Members with Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response at the Department of Health and Human Services (HHS); Brian Shuy, Chief of Staff to Dr.